QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. (Q37764874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

quality-adjusted life year

5 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Lisa A Prosser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Keiko Asakawa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

David Feeny

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Pharmacoeconomics & Outcomes Research

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

293-308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health

5 February 2020

cites work

1 reference

Calculating QALYs, comparing QALY and DALY calculations.

21 January 2018

1 reference

Preference-based measures in economic evaluation in health care

21 January 2018

1 reference

Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations

21 January 2018

1 reference

Improving decision analyses: parent preferences (utility values) for pediatric health outcomes

21 January 2018

1 reference

Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland

21 January 2018

1 reference

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health

21 January 2018

1 reference

Development, reliability and validity of a new measure of overall health for pre-school children.

21 January 2018

1 reference

Implications of spillover effects within the family for medical cost-effectiveness analysis.

21 January 2018

1 reference

Health state preference scores of children with spina bifida and their caregivers.

21 January 2018

1 reference

Lessons from cost-effectiveness research for United States public health policy.

21 January 2018

1 reference

Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.

21 January 2018

1 reference

Projected costs, risks, and benefits of expanded newborn screening for MCADD.

21 January 2018

1 reference

International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions.

21 January 2018

1 reference

Pneumococcal conjugate vaccine: review of cost-effectiveness studies in Australia, North America and Europe

21 January 2018

1 reference

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

21 January 2018

1 reference

Measurement of health state utilities for economic appraisal

21 January 2018

1 reference

Multi-attribute health status classification systems. Health Utilities Index

21 January 2018

1 reference

EQ-5D: a measure of health status from the EuroQol Group

21 January 2018

1 reference

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

21 January 2018

1 reference

Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

21 January 2018

1 reference

The estimation of a preference-based measure of health from the SF-36.

21 January 2018

1 reference

A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.

21 January 2018

1 reference

Not all "quality-adjusted life years" are equal.

21 January 2018

1 reference

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

21 January 2018

1 reference

US norms for six generic health-related quality-of-life indexes from the National Health Measurement study

21 January 2018

1 reference

Variation in the estimation of quality-adjusted life-years by different preference-based instruments

21 January 2018

1 reference

Comparing utility scores before and after hearing-aid provision : results according to the EQ-5D, HUI3 and SF-6D.

21 January 2018

1 reference

Utilities of the EQ-5D: transferable or not?

21 January 2018

1 reference

Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3.

21 January 2018

1 reference

Parental perspectives of the health status and health-related quality of life of teen-aged children who were extremely low birth weight and term controls

21 January 2018

1 reference

Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.

21 January 2018

1 reference

Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel

21 January 2018

1 reference

Cost-benefit analysis of universal tandem mass spectrometry for newborn screening

21 January 2018

1 reference

Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry

21 January 2018

1 reference

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis

21 January 2018

1 reference

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

21 January 2018

1 reference

Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

21 January 2018

1 reference

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies

21 January 2018

1 reference

Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis

21 January 2018

1 reference

Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

21 January 2018

1 reference

Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.

21 January 2018

1 reference

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program

21 January 2018

1 reference

Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model

21 January 2018

1 reference

Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.

21 January 2018

1 reference

Invasive meningococcal and pneumococcal disease in Switzerland: cost?utility analysis of different vaccine strategies

21 January 2018

1 reference

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.

21 January 2018

1 reference

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

21 January 2018

1 reference

Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.

21 January 2018

1 reference

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

21 January 2018

1 reference

Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France

21 January 2018

1 reference

Cost-utility analysis of the cochlear implant in children.

21 January 2018

1 reference

The effect of cochlear implant use in postlingually deaf adults.

21 January 2018

1 reference

The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.

21 January 2018

1 reference

Hearing-impaired children in the United Kingdom, IV: cost-effectiveness of pediatric cochlear implantation.

21 January 2018

1 reference

Health status and health-related quality of life preference-based outcomes of children who are aged 7 to 9 years and have bilateral permanent childhood hearing impairment.

21 January 2018

1 reference

A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures.

21 January 2018

1 reference

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

21 January 2018

1 reference

A review of health utilities across conditions common in paediatric and adult populations

21 January 2018

1 reference

Decision analysis for resource allocation in health care

21 January 2018

1 reference

Bias in published cost effectiveness studies: systematic review

21 January 2018

1 reference

Retaining, and enhancing, the QALY.

21 January 2018

1 reference

Toward a consensus on the QALY.

21 January 2018

1 reference

Preference-Based EQ-5D index scores for chronic conditions in the United States

21 January 2018

1 reference

Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses

21 January 2018

1 reference

Utilities should not be multiplied: evidence from the preference-based scores in the United States

21 January 2018

1 reference

Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study

21 January 2018

1 reference

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample

21 January 2018

1 reference

Comparison of 5 health-related quality-of-life indexes using item response theory analysis

21 January 2018

1 reference

Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.

21 January 2018

1 reference

Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.

21 January 2018

1 reference

Health and Economic Implications of a Work-Site Smoking-Cessation Program

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.10.24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20545594%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference